scPharmaceuticals Inc.

NASDAQ (USD): scPharmaceuticals Inc. (SCPH)

Last Price

3.35

Today's Change

+0.15 (4.68%)

Day's Change

3.10 - 3.36

Trading Volume

204,187

Overview

Market Cap

167 Million

Shares Outstanding

50 Million

Avg Volume

450,211

Avg Price (50 Days)

3.41

Avg Price (200 Days)

4.22

PE Ratio

-1.78

EPS

-1.88

Earnings Announcement

11-Mar-2025

Previous Close

3.20

Open

3.15

Day's Range

3.1 - 3.36

Year Range

3.075 - 6.54

Trading Volume

204,187

Price Change Highlight

1 Day Change

4.69%

5 Day Change

1.21%

1 Month Change

-6.69%

3 Month Change

-16.87%

6 Month Change

-25.88%

Ytd Change

-6.16%

1 Year Change

-35.45%

3 Year Change

-36.55%

5 Year Change

-46.91%

10 Year Change

-76.24%

Max Change

-76.24%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment